Centessa Pharmaceuticals PLC
NASDAQ:CNTA

Watchlist Manager
Centessa Pharmaceuticals PLC Logo
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Watchlist
Price: 18.08 USD 6.35% Market Closed
Market Cap: 2B USD
Have any thoughts about
Centessa Pharmaceuticals PLC?
Write Note

Centessa Pharmaceuticals PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Centessa Pharmaceuticals PLC
Revenue Peer Comparison

Comparables:
EXAI
AUTL
BCYC
IMCR
GNS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Revenue
$6.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Revenue
ÂŁ20.1m
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Revenue
$1.7m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Revenue
$36.9m
CAGR 3-Years
46%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Revenue
ÂŁ249.4m
CAGR 3-Years
102%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Revenue
ÂŁ668.8m
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
6%

See Also

What is Centessa Pharmaceuticals PLC's Revenue?
Revenue
6.9m USD

Based on the financial report for Dec 31, 2023, Centessa Pharmaceuticals PLC's Revenue amounts to 6.9m USD.

Back to Top